Stock Market News1 month Is It Time to Sell Eli Lilly and Pfizer Stocks? Yahoo Finance
Is It Time to Sell Eli Lilly and Pfizer Stocks?.
Eli Lilly (LLY) · Pfizer (PFE)
X43 mins Better Income Stock: Pfizer or Altria Group? Yahoo Finance
X16 hours Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know Zacks
X1 day Pfizer: Time And Patience Ran Out (Rating Downgrade) Seeking Alpha
X2 days Eli Lilly, Novo Nordisk Stocks Rise. Only One Is Operating From a Position of Strength. Yahoo Finance
X2 days Should Value Investors Buy Pfizer (PFE) Stock? Zacks
X2 days Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It Zacks
X2 days Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know Zacks
X2 days Lilly’s Zepbound Receives FDA Approval for Sleep Apnea Zacks
X2 days Eli Lilly, Novo Nordisk Stocks Rise. One of These Obesity Drugmakers Just Hit a Landmark. Yahoo Finance
X2 days Stocks to Watch Monday: Honda, Novo Nordisk, Eli Lilly, Xerox Yahoo Finance
X2 days Pfizer’s 2025 ‘Boring’ Outlook Had A Nice Surprise That Was Overlooked Seeking Alpha
X4 days Is Now a Good Time to Buy the Dip in Eli Lilly Stock? Yahoo Finance
X5 days Eli Lilly’s Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive? Investor's Business Daily
X5 days Stocks to Watch Friday: Trump Media, Novo Nordisk, Eli Lilly, Tesla Yahoo Finance
X5 days Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture YouTube
X5 days Nvidia, Eli Lilly lead Friday’s market cap stock movers Investing.com
X5 days There’s a New Obesity King The Wall Street Journal
X5 days Eli Lilly: Improved Competitive Position In Obesity Market, But Strong Execution Is A Must Now Seeking Alpha
X5 days LLY Stock Up as FDA Removes Mounjaro, Zepbound From Shortage List Zacks
X5 days FedEx, Eli Lilly, Occidental rise premarket; Nike, Novo Nordisk fall Investing.com
X5 days Novo Nordisk’s new weight-loss drug works better, but not as well as expected MarketWatch
X5 days Pharma Stock Roundup: PFE’s 2025 Outlook, MRK & ABBV’s M&A Deals Zacks
X5 days Market Digest: ACN, ATO, OGE, PFE, PNW, JCI, DASH Yahoo Finance
X6 days Why Pfizer (PFE) Dipped More Than Broader Market Today Zacks
X6 days Eli Lilly dips despite FDA confirming shortage of GLP-1 tirzepatide is over Investing.com
X6 days IBD 50’s Hims & Hers Tumbles After FDA Pulls Lilly’s Weight-Loss Drug From Shortage List Investor's Business Daily
X6 days FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage CNBC
X6 days Zealand Pharma And Eli Lilly: Strategic Focus On Weight Management And Future Outlook Seeking Alpha
X7 days Pfizer Momentum Shift Makes Me Less Bullish (Technical Analysis) Seeking Alpha
X7 days Pfizer: I’m Short-Term Skeptical, Long-Term Positive Post 2025 Guidance Call Seeking Alpha
X7 days Pfizer Stock Up 5% as 2025 Guidance Meets Investor Expectations Zacks
X1 week Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy Investor's Business Daily
X1 week Eli Lilly’s Alzheimer’s treatment approved in China Investing.com
X1 week Eli Lilly Alzheimer’s drug donanemab approved in China Investing.com
X1 week Final Trade: GOOG, SAIA, X, PFE YouTube
X1 week Eli Lilly (LLY) Stock Moves -0.05%: What You Should Know Zacks
X1 week Pfizer climbs 4% on 2025 outlook YouTube
X1 week Comments From Trump, Pfizer CEO Hit UnitedHealth, CVS Stock Yahoo Finance
X1 week Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more CNBC
X1 week NVS vs. LLY: Which Stock Should Value Investors Buy Now? Zacks
X1 week Pfizer Inc. (PFE) Full-Year 2025 Financial Guidance Conference Call (Transcript) Seeking Alpha
X1 week Guggenheim: Can see Pfizer reaching $10 billion in sales by 2030 YouTube
X1 week 15 Billion Reasons to Love Eli Lilly Stock Right Now Yahoo Finance
X1 week Pfizer 2025 profit forecast soothes investor jitters as it pursues turnaround Investing.com
X1 week Pfizer Stock Jumps On Mixed, But ‘Marginally Encouraging,’ 2025 Outlook Investor's Business Daily
X1 week Stocks making the biggest moves premarket: Pfizer, Tesla, SolarEdge, Red Cat and more CNBC
X1 week Pfizer Sees 2025 Revenue in Line With Wall Street Views The Wall Street Journal
X1 week AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back? Investor's Business Daily
X1 week Nvidia, Evgo and Affirm fall premarket; Pfizer and SolarEdge rise Investing.com
X1 week Pfizer forecasts in line 2025 profit as it seeks turnaround Investing.com
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.